Neurology

Featured Research

Everolimus Shows Benefit Against SEGA Tumors While there is no “magic bullet” for tuberous sclerosis complex (TSC), researchers have demonstrated the power of everolimus to treat acute symptoms and, more significantly, reverse the effects of a genetic defect associated with the disease.

Read Featured Research

Division Summary

Research and Training Details
Faculty 42
Joint Appointment Faculty 1
Research Fellows and Post Docs 1
Research Graduate Students 5
Total Annual Grant Award Dollars $1,522,316
Total Annual Industry Award Dollars $1,085,089
Clinical Activities and Training
Staff Physicians 1
Clinical Fellows 5
Inpatient Encounters 6,970
Outpatient Encounters 33,193